News Conference News ESC 2025 HI-PRO: Oral Apixaban for 1 Year Protective, Safe in Provoked VTE Patients Caitlin E. Cox September 01, 2025
News Opinion Editor's Corner ACC 2025 What’s Going to Be Hot at ACC 2025? Michael O'Riordan March 26, 2025
News Conference News TCT 2024 PAD Patients’ Views on Decisions and Outcomes Hinge on Sex, Race/Ethnicity: ELEGANCE L.A. McKeown November 04, 2024
News Daily News No Increased Bleeding With Alteplase in Stroke Patients on DOACs: Registry Data Yael L. Maxwell February 15, 2022
News Daily News Pulmonary Embolism in COVID-19 Patients: New Numbers, Little Consensus Michael O'Riordan April 29, 2020
News Daily News Bleeding Risk Similar for Peripheral, Coronary Revascularization: EUCLID Caitlin E. Cox October 16, 2019
News Conference News TCT 2019 ‘Spooky’ Signal Still Haunts Paclitaxel DCBs in PAD, but Updated Analysis Reassures L.A. McKeown September 28, 2019
News Daily News FDA Panel Talks Labeling, Urges Cooperation for Paclitaxel Mortality Signal in PAD L.A. McKeown June 20, 2019
News Daily News US Data Convey the Scope of Bleeding in Lower-Extremity Peripheral Interventions Caitlin E. Cox June 18, 2019
News Conference News SCAI 2019 Paclitaxel DCBs and CHIP: SCAI Kicks Off With Two Hot-Potato Topics Yael L. Maxwell May 21, 2019
News Features Peripheral Vision: As Office-Based Practices Proliferate, Who Is Watching Out for Patients? Caitlin E. Cox May 01, 2019
News Conference News ISET 2019 PVI in Symptomatic Lower-Extremity PAD Offers Multiple Benefits, Even 2.5 Years Later Caitlin E. Cox February 07, 2019
News Conference News ACC 2017 My Takeaways From ACC 2017: Even With a Sea Change, the Tide Takes Its Time Shelley Wood March 23, 2017
News Opinion Editor's Corner TCT 2016 TCT 2016: Inspiration and Perspiration Greet Left Main Stenting, Hoop Dreams, Valve Innovation, and Election Fever Shelley Wood October 24, 2016
News Daily News FDA: ROCKET AF Results Not Affected by Faulty INR Testing in Warfarin Arm Michael O'Riordan October 11, 2016
News Conference News VIVA 2016 Long PAD Lesions Respond Well to DCB, but Optimal Patient Selection Still Unclear L.A. McKeown September 21, 2016
News Conference News VIVA 2016 Positive Results Continue at 2 Years for Paclitaxel-Eluting PAD Stent L.A. McKeown September 20, 2016